Taglietti Marco
SEC-identified person · CIK 1408870 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Aquestive Therapeutics, Inc. AQST | Director | filed 2021 - 2026 |
| Scynexis INC SCYX | Director · Chief Executive Officer | filed 2014 - 2022 |
| Delcath Systems, INC. DTCH | Director | filed 2014 - 2020 |
| Nephrogenex, Inc. NRX | Director | filed 2014 - 2015 |
| Forest Laboratories, LLC frx | Sr.VP-R&D & Chief Medical Off. | filed 2007 - 2014 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.